Cas:14464-30-3 1-(Octanoyloxy)-2,5-pyrrolidinedione manufacturer & supplier

We serve Chemical Name:1-(Octanoyloxy)-2,5-pyrrolidinedione CAS:14464-30-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-(Octanoyloxy)-2,5-pyrrolidinedione

Chemical Name:1-(Octanoyloxy)-2,5-pyrrolidinedione
CAS.NO:14464-30-3
Synonyms:octanoic acid succinimidyl ester;N-(octanoyloxy)succinimide;Octansaeure-sec-butylester;Octanoic acid,2-butyl ester;2,5-dioxopyrrolidin-1-yl octanoate;sec-butyl caprylate;octanoic acid N-hydroxysuccinimide ester;Octanoic acid,1-methylpropyl ester;2,5-Pyrrolidinedione, 1-[(1-oxooctyl)oxy]-;octanoic acid N-succinimidyl ester;octanoic acid sec-butyl ester;Caprylsaeure-2-butanester;1-(Octanoyloxy)-2,5-pyrrolidinedione;Sec-butyl octanoate
Molecular Formula:C12H19NO4
Molecular Weight:241.284
HS Code:2925190090

Physical and Chemical Properties:
Melting point:61-63ºC
Boiling point:333.2±25.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.492
PSA:63.68000
Exact Mass:241.131409
LogP:1.38

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like octanoic acid succinimidyl ester chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,Sec-butyl octanoate physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Octanoic acid,2-butyl ester Use and application,Caprylsaeure-2-butanester technical grade,usp/ep/jp grade.


Related News: Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 1-(Octanoyloxy)-2,5-pyrrolidinedione manufacturer This time frame optimizes the opportunity to respond to treatment with an HMA prior to declaring treatment failure, as per NCCN Guidelines. Patients are randomized at a 2:1 ratio into two study arms: IV rigosertib plus Best Supportive Care versus Physician��s Choice plus Best Supportive Care. 1-(Octanoyloxy)-2,5-pyrrolidinedione supplier Johnson & Johnson’s Darzalex has comfortably been the only CD38 multiple myeloma drug on the market for years until Sanofi hit the scene last year with Sarclisa. Now, just as the competition’s slated to intensify, the U.S. company is building its case with new patient survival data. 1-(Octanoyloxy)-2,5-pyrrolidinedione vendor Most of California’s COVID-19 restrictions were lifted on Tuesday and the nation’s most populous state is poised to come roaring back,” according to Gov. Gavin Newsom.
State social distancing rules and capacity limits at restaurants, bars, supermarkets, gyms, stadiums and other locations have been rolled back, and masks will no longer be required for vaccinated people in most settings, the Associated Press reported.
However, businesses and counties can still require them.
In March 2020, California became the first in the United States to impose a statewide shutdown. More people tested positive for the virus (3.8 million to date) and more people died (more than 63,000) in California than anywhere else in the country, but it had a lower per capita death rate than most others, the AP reported.
California now has one of the lowest infection rates (below 1%) in the U.S.
That low rate and a rising number of vaccinated residents — over 70% of adults have had at least one shot — led Newsom to announce in April that most pandemic restrictions would be lifted June 15, the AP reported.
However, the governor has repeatedly said the reopening doesn’t mean the pandemic is over, and some public health measures will still be in place for “mega events. 1-(Octanoyloxy)-2,5-pyrrolidinedione factory J&J, in a statement, confirmed that the FDA authorized the two batches, but did not acknowledge the doses regulators decided should be tossed.